Trends in Molecular Medicine
OpinionTRPV1 antagonists: the challenges for therapeutic targeting
Section snippets
The TRPV1 receptor – strategically positioned at the root of the problem
The vanilloid (capsaicin) receptor TRPV1 (transient receptor potential cation channel, subfamily V, member 1) is the oldest and best-characterized member of the transient receptor potential (TRP) family of receptors and is activated by various unrelated stimuli (hence the term ‘polymodal’) [1]. The cloning and characterization of TRPV1 by Julius and coworkers in 1997 [2] generated a huge upsurge in research interest among scientists in investigating several aspects of TRPV1 receptor biology,
The TRPV1 receptor: also present in non-neuronal cells
Although TRPV1 is expressed predominantly in primary sensory (dorsal root and trigeminal ganglion) neurons, it is also present (albeit at much lower levels compared with sensory neurons) in various non-neuronal cells, such as keratinocytes [19], urothelial cells [20], smooth muscle cells [21], endothelial cells [22] and cells of the immune system, including mast cells, lymphocytes and dendritic cells (reviewed in [23]). The biological role of the receptors in each of these cells remains
TRPV1: a ‘polymodal’ receptor with complex regulation
TRPV1 is a heat-sensitive channel (a ‘thermoTRP’) that serves as a target for several noxious xenobiotics, including both plant products (e.g. capsaicin, resiniferatoxin) and animal venoms (from spiders and jellyfish) (reviewed in [1]). Various inflammatory mediators (including protons, NGF and prostaglandin metabolites) and signaling components are also believed to be involved in sensitization and/or activation of peripheral TRPV1 receptors (reviewed in 1, 29, 51). Activated peripheral TRPV1
TRPV1 gene polymorphism: pain and beyond
Humans report strikingly variable pain experience in response to similar noxious stimuli. There is a growing speculation that part of this inter-individual variability in pain response and therapy could be associated with genetic polymorphism [67]. Gene polymorphism might impede on the generation, transmission and processing of nociceptive information or increase the local availability of active analgesic or its pharmaco-dynamic properties. Investigations at the gene level have commenced to
TRPV1 antagonists in clinical development: soothing the pain but lighting a fire?
Given the crucial role of TRPV1-mediated signaling in the pain-transmission process, therapeutic intervention into TRPV1 signaling is being attempted by pharmaceutical companies via many different approaches, some of which have shown promising signs at various stages of discovery, preclinical or clinical research. Investigators at Grünenthal demonstrated that TRPV1 blockade using siRNA and antisense oligonucleotide platforms represents a valid approach for developing new pain therapeutics 81, 82
Concluding remarks
Targeting TRPV1 represents a new strategy in pain relief. Many pharmaceutical companies have focused their discovery efforts on developing TRPV1 antagonists for the treatment of human pain disorders. Of the several TRPV1 receptor antagonists reported in the literature, a number have entered into clinical trials successfully (e.g. NGD8243, SB-705498, AMG 517, AMG 986, AMG 628, AZD1386, GRC 6211, SAR-115740, M68008, AZD1386 and JTS-653) (Table 1). Most of the trial drugs are still under clinical
Disclosure statement
N.K-J. was involved in the preclinical development of GRC 6211, a TRPV1 antagonist that was subsequently licensed to Eli Lilly. A.S. is a member of the Scientific Advisory Board to Glenmark.
References (92)
The cloned capsaicin receptor integrates multiple pain-producing stimuli
Neuron
(1998)Role of vanilloid receptors in thermal allodynia and hyperalgesia in diabetic mice
Eur. J. Pharmacol.
(2001)- et al.
The therapeutic potential of TRPV1 (VR1) antagonists: clinical answers await
Drug Discov. Today
(2004) - et al.
New perspectives on enigmatic vanilloid receptors
Trends Neurosci.
(2000) Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB1 and TRPV1 receptors
Exp. Neurol.
(2007)TRPV1 channels mediate long term depression atsynapses on hippocampal interneurons
Neuron
(2008)Brain TRPV1: a depressing TR(i)P down memory lane?
Trends Pharmacol. Sci.
(2008)Human brain endothelium: co expression and function of vanilloid and endocannabinoid receptors
Brain Res. Mol. Brain Res.
(2004)- et al.
Topical capsaicin for pruritic psoriasis
J. Am. Acad. Dermatol.
(1994) TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes
Cell
(2006)
Tissue acidosis in nociception and pain
Prog. Brain Res.
Negatively charged 2- and 10-micron particles activate vanilloid receptors, increase cAMP, and induce cytokine release
Toxicol. Appl. Pharmacol.
The urothelium: passive bystander or active participant?
Urology
Urinary bladder urothelium: molecular sensors of chemical/thermal/mechanical stimuli
Vascul. Pharmacol.
TRPV1: a therapeutic target for novel analgesic drugs?
Trends Mol. Med.
Resiniferatoxin, an ultrapotent capsaicin analogue, has antiemetic properties in the ferret
Neuropharmacology
Body-temperature maintenance as a predominant function of the vanilloid receptor TRPV1
Trends Pharmacol. Sci.
Proinflammatory mediators modulate the heat-activated ion channel TRPV1 via the scaffolding protein AKAP79/150
Neuron
Molecular determinants of vanilloid sensitivity in TRPV1
J. Biol. Chem.
Gadolinium activates and sensitizes the vanilloid receptor TRPV1 through the external protonation sites
Mol. Cell. Neurosci.
Novel gating and sensitizing mechanism of capsaicin receptor (TRPV1): tonic inhibitory regulation of extracellular sodium through the extra cellular protonation site on TRPV1
J. Biol. Chem.
Protein kinase C contributes to abnormal capsaicin responses in DRG neurons from cats with feline interstitial cystitis
Neurosci. Lett.
Analysis of the native quaternary structure of the vanilloid receptor-1
J. Biol. Chem.
Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCɛ-mediated phosphorylation at S800
Pain
The mu opioid receptor A118G gene polymorphism moderates effects of trait anger-out on acute pain sensitivity
Pain
Are μ opioid receptor polymorphisms important for clinical opioid therapy? Trends Mol
Med.
Catechol-o-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli
Pain
Genetic influence on variability in human acute and experimental pain sensitivity associated with gender, ethnicity and psychological temperament
Pain
TRPV1-null mice are protected from diet-induced obesity
FEBS Lett.
Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo
Biochem. Biophys. Res. Commun.
TRP channels: targets for the relief of pain
Biochim. Biophys. Acta
Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans
Pain
Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat
Neurosci.
The effects of the TRPV1 receptor antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans
Pain
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
Nat. Rev. Drug Discov.
The capsaicin receptor: a heat activated ion channel in pain pathway
Nature
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
Science
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
Nature
RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat
Eur. J. Neurosci.
Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms
Curr. Pharm. Des.
TRPs: links to schizophrenia? Biochim
Biophys. Acta
Transient release potential channels in Alzheimer's disease
Biochim. Biophys. Acta
TRPV1 receptors in the CNS play a key role in broad spectrum analgesia of TRPV1 antagonists
J. Neurosci.
Expression of vanilloid receptor subtype-1 in cutaneous sensory fibers, mast cells and epithelial cells of appendage structure
Exp. Dermatol.
Cited by (114)
Lipid raft disruption as an opportunity for peripheral analgesia
2024, Current Opinion in PharmacologyTRP channels in inflammatory bowel disease: Potential therapeutic targets
2022, Biochemical PharmacologyDesign, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists
2019, European Journal of Medicinal ChemistryCitation Excerpt :TRPV1, the transient receptor potential vanilloid 1, is arguably the best-characterized member of the transient receptor potential (TRP) family: it is a calcium permeable nonselective ion channel gated by a wide range of stimuli such as exogenous ligands (e.g., capsaicin or resiniferatoxin), heat (>43 °C), acid (pH < 6.8), and endogenous substances (e.g., anandamide and oxidative metabolites of linoleic acid), and is a central nociceptor on sensory afferent neurons [1–5].
The investigation of allosteric regulation mechanism of analgesic effect using SD rat taste bud tissue biosensor
2019, Biosensors and Bioelectronics